BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

88.17

-0.96 (-1.08%)

At close: Oct 30, 2026, 4:00 PM EDT

88.05

-0.12 (-0.13%)

After-hours: Oct 30, 2026, 7:51 PM EDT

BioNTech SE Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,650	2,870	2,751	3,819	17,311	18,977
Revenue Growth	-7.94%	4.32%	-27.96%	-77.94%	-8.78%	3834.63%
Gross Profit	2,031	2,259	2,210	3,219	14,316	16,065
Operating Income	-1,817	-1,267	-1,286	971.8	11,918	14,847
Net Income	-1,686	-1,136	-665.3	930.3	9,434	10,293
Earnings Per Share	-6.80	-4.70	-2.77	3.83	37.77	39.63
EPS Growth	-	-	-	-89.86%	-4.69%	65950.00%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
COVID-19 Vaccine	1,828	1,995	2,432	3,776	17,145
Out-Licensing	-	613	-	-	-
Other Sales	209.2	261.6	319	42.8	165.4
Other	-	184.6	140.6	105	0
Revenue (Total)	2,780	3,055	2,892	3,924	17,311

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	13,464	13,741	15,844	16,549	14,065	2,074
Total Debt	316.1	267.4	254.2	219.1	212.2	301.5
Net Cash (Debt)	13,148	13,473	15,590	16,330	13,852	1,773
Net Cash Growth	-1.62%	-13.58%	-4.53%	17.88%	681.38%	60.10%
Net Cash Per Share	53.04	55.74	64.85	67.28	55.45	6.83

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	679.7	456	207.7	5,371	13,577	889.7
Capital Expenditures	-210.5	-175.1	-286.5	-250.1	-329.2	-127.5
Free Cash Flow	469.2	280.9	-78.8	5,121	13,248	762.2
Free Cash Flow Growth	-	-	-	-61.34%	1638.15%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	76.62%	78.70%	80.32%	84.29%	82.70%	84.66%
Operating Margin	-68.57%	-44.14%	-46.73%	25.45%	68.85%	78.23%
Pretax Margin	-61.49%	-36.61%	-24.63%	31.06%	74.83%	79.29%
Profit Margin	-63.64%	-39.59%	-24.18%	24.36%	54.50%	54.24%
FCF Margin	17.71%	9.79%	-2.86%	134.10%	76.53%	4.02%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	24.40	3.62	5.32
Forward PE	-	100.62	100.62	67.81	8.27	8.07
P/FCF Ratio	42.15	69.41	-	4.43	2.58	71.83
PS Ratio	7.32	6.79	9.59	5.94	1.97	2.89